Revvityブログ 発見から治療までのイノベーションを促進 Latest Programmable depletion with CRISPR–Cas9: what DASH is, why it works, and where to use it. NGS December 2, 2025 - 4 min read Read - すべて -Agricultural GenomicsAssay Development WorkflowsAutomationBiobankingBiologicsBiomarker DetectionCancerCancer Research SolutionsCell and Gene TherapyClinical GenomicsDisease ResearchDrug DevelopmentFunctional Genomic ScreeningHigh Content Screening InstrumentsInfectious Disease ResearchInfectious DiseasesMetabolic researchNeurodegenerationNeuroscience ResearchNGSPhysiological Model SolutionsPrecision MedicineReproductive HealthSmall Molecule Drug Discovery - すべて -AlphaScreen, AlphaLISA, AlphaLISA SureFire UltraAutomated Liquid HandlingBioLegend Cell AnalysisCE DNA, RNA & Protein CharacterizationCell Counting and Image CytometryCellular ImagingCentrifugesDNA, RNA & Protein CharacterizationDrug Discovery Reagents and MicroplatesHigh-Content ImagingIn Vivo Bioluminescent ImagingIn Vivo Fluorescent ImagingIn Vivo ImagingInfectious DiseasesIntegrated Lab AutomationMultimode Microplate ReadersNext Generation SequencingNGS Library PrepNGS OEM & Custom SolutionsNucleic Acid PurificationOmni Homogenizers and SonicatorsPreclinical Oncology ServicesRadiochemicals 検索 Physiological Model Solutions, Small Molecule Drug Discovery Bioprinting workflow enables high-throughput drug discovery in 3D cell cultures. May 21, 2024 - 2 min read Read Neurodegeneration How CRISPR can identify regulators of Alzheimer’s-related protein tau? March 31, 2024 - 4 min read Read ご質問がございましたら、お気軽にお問い合わせください。 お問合せ